New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 28, 2014
04:55 EDTSI, SI, SI, THOR, THOR, THOR, STJ, STJ, STJ, ATRC, ATRC, ATRC, CADX, CADX, CADX, COV, COV, COV, CRY, CRY, CRY, EW, EW, EW, HTWR, HTWR, HTWR, ISRG, ISRG, ISRG, MDT, MDT, MDT, MYGN, MYGN, MYGN, RTIX, RTIX, RTIX, WTKWY, WTKWY, WTKWYAmerican Association for Thoracic Surgery to hold annual meeting
94th Annual Meeting of AATS is being held in Toronto on April 26-30.
News For SI;RTIX;MYGN;MDT;ISRG;HTWR;EW;CRY;COV;CADX;ATRC;STJ;THOR;WTKWY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
November 13, 2014
14:50 EDTMDTLonestar Capital to shut down by mid-2015, WSJ reports
Subscribe for More Information
14:45 EDTMDTLonestar capital to shut down, DJ reports
Subscribe for More Information
13:27 EDTCOV, MDTMedtronic likely to continue to make new highs, Barron's says
Subscribe for More Information
November 12, 2014
10:01 EDTRTIXRTI Surgical announces publication of study highlighting nanOss
Subscribe for More Information
08:02 EDTTHORCredit Suisse to hold a conference
Subscribe for More Information
07:27 EDTWTKWY, RTIXNorth American Spine Society to hold annual meeting
Subscribe for More Information
07:23 EDTMDTMedtronic volatility elevated into Q2 and outlook
Medtronic November call option implied volatility is at 23, December is at 20, January is at 19, February is at 18; compared to its 26-week average of 19 according to Track Data, suggesting large near term price movement into the expected release of Q2 results on November 18.
November 11, 2014
07:24 EDTCOV, MDTMedtronic submits commitments to EU related to Covidien merger
Subscribe for More Information
November 10, 2014
15:54 EDTCOVAmerican Society of Nephrology to hold a conference
Subscribe for More Information
14:49 EDTTHORT. Rowe Price reports 10.7% passive stake in Thoratec
Subscribe for More Information
10:04 EDTMYGNOn The Fly: Analyst Initiation Summary
Subscribe for More Information
09:10 EDTMDTMedtronic announces Japanese approval, launch of Evera MRI SureScan ICD
Subscribe for More Information
08:36 EDTCOVBSD Medical names Clint Carnell as president and CEO
Subscribe for More Information
07:57 EDTISRGIntuitive Surgical survey positive on hernia opportunity, says JPMorgan
JPMorgan said its survey of 25 U.S.-based general surgeons who have used da Vinci for hernia procedures yielded positive outlook on the hernia opportunity for Intuitive Surgical. The firm says the complexity of the robot does not appear to be an issue. It keeps an Overweight rating on Intuitive with a $550 price target.
06:18 EDTMYGNMyriad Genetics initiated with an Underweight at Morgan Stanley
Subscribe for More Information
November 7, 2014
21:13 EDTISRGIntuitive Surgical management to meet with SunTrust
Subscribe for More Information
20:47 EDTTHORThoratec management to meet with Piper Jaffray
Group dinner to be held in New York on November 13 hosted by Piper Jaffray.
10:00 EDTEWOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
07:23 EDTMYGNMyriad myPath Melanoma study shows 43% reduction in indeterminate diagnoses
Myriad Genetics presented results from a prospective clinical utility study of its Myriad myPath Melanoma test at the 2014 American Society of Dermatopathology, or ASDP, annual meeting in Chicago, IL. Myriad myPath Melanoma is a genetic test that differentiates malignant melanoma from benign skin lesions across all major melanoma subtypes. Key findings of this clinical utility study included a 43% reduction in indeterminate diagnoses and a 49% change in physicians' treatment recommendations for patients. The study evaluated the impact of the Myriad myPath Melanoma diagnostic test on dermatopathologists' diagnoses and intended treatment recommendations for 218 patients with pigmented skin lesions that were considered difficult to diagnose. The dermatopathologists recorded their diagnoses and treatment plans before and after receiving the myPath Melanoma test results.
06:44 EDTEWEdwards Lifesciences downgraded to Neutral from Buy at Sterne Agee
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use